The "Cunning Mouse" Metaphor: Adaptive Escape Pathways in Metabolic Disease

Description This work presents the “Cunning Mouse” metaphor as a conceptual framework to understand adaptive escape behaviors in metabolic disease. It reframes insulin resistance, altered substrate utilization, and pathway rerouting not as simple regulatory failures, but as intelligent survival responses to sustained physiological stress, constraint, and overload. By viewing disease biology as an adaptive system that seeks alternative routes when classical pathways are blocked, this narrative encourages a shift from adversarial suppression toward interpretive, physiology-first understanding of chronic metabolic disorders. The work is intended as a conceptual and narrative perspective, without methodological or therapeutic claims. KeywordsCunning Mouse Metaphor; Elusive Hyperglycemia; Neuroendocrine Dysregulation; Organ-Dominated Insulin Resistance; Insulin Trap Syndrome; Internal Hyperglycemia Unawareness; Counter-regulatory Hormones; Hepatic and Renal Gluconeogenesis; Blood Viscosity; Fluid-Electrolyte Imbalance; Personalized Diabetes Management; Narrative Medicine in Endocrinology *"The author has published 30+ research articles and hypotheses on Zenodo covering [Diabetes]. Researchers, scientists, institutions, or students interested in:*> - *Collaboration or joint research*> - *Pilot studies or experimental validation*> - *Discussion or peer exchange*> - *Building upon or extending these ideas*Invitation* *"Researchers interested in collaboration or discussion are welcome to contact the author at [ email]"*- adityadr48@gmail.com*"The author has filed 20+ patent applications in the field of Diabetes covering novel hypotheses and therapeutic approaches. Applications are currently under examination. Researchers and institutions interested in licensing, collaboration, or pilot studies are welcome to contact the author.""The author has filed PCT international patent applications at WIPO International Bureau in the field of Diabetes research. Applications are currently under international examination.* > *Researchers, institutions and companies interested in collaboration, pilot studies or licensing are welcome to contact the author.*